Current Report Filing (8-k)
April 12 2018 - 4:14PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
April
9, 2018
Commission
File #:
000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
30-0791746
(IRS
Employer Identification Number)
555
Madison Avenue, 5
th
Floor
New
York, NY
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
Mr.
Hingge Hsu notified Tauriga Sciences, Inc. (the “Company”) of his intention to resign from his position on the Board
of Directors of the Company (the “Board”), effective April 9, 2018, in order to pursue other business opportunities
that required his attention and time, and was not due to any disagreement with the Company regarding any matter related to the
Company’s operations, policies or practices. Mr. Hsu’s service to the board has been greatly appreciated by management
and the other board members of the Company. He has served on the Board since January 2014.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Tauriga Sciences, Inc.
|
|
|
|
Date:
April 12, 2018
|
By:
|
/s/
Seth M. Shaw
|
|
Name:
|
Seth
M. Shaw
|
|
Title:
|
Chief
Executive Officer
|